Skip to Content
AP National Business

Rigel: Q4 Earnings Snapshot

KION
By
Published 1:25 PM

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported fourth-quarter net income of $1.4 million.

The South San Francisco, California-based company said it had profit of 1 cent per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 7 cents per share.

The drug developer posted revenue of $51.3 million in the period.

For the year, the company reported a loss of $58.6 million, or 34 cents per share. Revenue was reported as $120.2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

Related Articles

BE PART OF THE CONVERSATION

KION 46 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content